T/CACM 1466-2023 Chronic Obstructive Pulmonary Disease (COPD) Preventive Intervention Guidelines

Scope

Main Technical Content: Foreword II. Introduction III. 1. Scope 2. Normative Reference Documents 3. Terms and Definitions 4. Epidemiological Characteristics 5. Etiology and Pathogenesis 6. Screening and Diagnosis 6.1. Screening for High-Risk Populations of COPD 6.2. Diagnosis and Staging of COPD 6.3. Traditional Chinese Medicine Diagnosis of COPD 7. Prevention/Intervention 7.1. Prevention Before Illness — High-Risk Populations of COPD 7.2. Prevention of Complications During Illness — Stable Phase of COPD 8. Follow-up and Monitoring 8.1. General Requirements 8.2. Follow-up for High-Risk Populations 8.3. Post-Recovery Prevention of Recurrence — Follow-up for Patients in the Stable Phase and during the Risk Window of Acute Exacerbation 8.4. Monitoring and Efficacy Evaluation 19. Appendix A (Informative) Pharmaceutical and Dietary Therapy 20. Appendix B (Normative) Dyspnea Scale (mMRC) 21. Appendix C (Normative) COPD Self-Assessment Test (CAT) 22. Appendix D (Normative) St. George's Respiratory Questionnaire (SGRQ) 23. Appendix E (Normative) Six-Minute Walk Test (6MWT) Record Form 24. Appendix F (Normative) Self-Assessment Scale for Anxiety (SAS) 25. Appendix G (Normative) Self-Assessment Scale for Depression (SDS) 26. References

Development Information

Related Standards